These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2287476)

  • 1. Clozapine: an atypical neuroleptic.
    Bruhwyler J; Chleide E; Mercier M
    Neurosci Biobehav Rev; 1990; 14(4):357-63. PubMed ID: 2287476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs.
    Ellenbroek BA; Peeters BW; Honig WM; Cools AR
    Psychopharmacology (Berl); 1987; 93(3):343-8. PubMed ID: 2893411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
    Ellenbroek BA; Artz MT; Cools AR
    Eur J Pharmacol; 1991 Apr; 196(1):103-8. PubMed ID: 1678712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine: guidelines for clinical management.
    Lieberman JA; Kane JM; Johns CA
    J Clin Psychiatry; 1989 Sep; 50(9):329-38. PubMed ID: 2670914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do central antiadrenergic actions contribute to the atypical properties of clozapine?
    Baldessarini RJ; Huston-Lyons D; Campbell A; Marsh E; Cohen BM
    Br J Psychiatry Suppl; 1992 May; (17):12-6. PubMed ID: 1418884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical neuroleptic, clozapine, exerts antidystonic activity in a mutant hamster model. Comparison with haloperidol.
    Richter A; Löscher W
    Eur J Pharmacol; 1993 Oct; 242(3):309-12. PubMed ID: 8281996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and behavioural properties of clozapine.
    Coward DM; Imperato A; Urwyler S; White TG
    Psychopharmacology (Berl); 1989; 99 Suppl():S6-12. PubMed ID: 2573106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics.
    Frye MA; Ketter TA; Altshuler LL; Denicoff K; Dunn RT; Kimbrell TA; Corá-Locatelli G; Post RM
    J Affect Disord; 1998 Mar; 48(2-3):91-104. PubMed ID: 9543198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
    Blackburn JR; Phillips AG
    Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of "seroquel" (ICI 204,636) in animal models for atypical properties of antipsychotics: a comparison with clozapine.
    Ellenbroek BA; Lubbers LJ; Cools AR
    Neuropsychopharmacology; 1996 Oct; 15(4):406-16. PubMed ID: 8887995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The atypical neuroleptic clozapine (Leponex)--current knowledge and recent clinical aspects].
    Klimke A; Klieser E
    Fortschr Neurol Psychiatr; 1995 May; 63(5):173-93. PubMed ID: 7782019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats.
    Goudie A; Taylor A
    Psychopharmacology (Berl); 1998 Feb; 135(4):392-400. PubMed ID: 9539264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine for the treatment of psychosis in Parkinson's disease: a review.
    Auzou P; Ozsancak C; Hannequin D; Moore N; Augustin P
    Acta Neurol Scand; 1996 Nov; 94(5):329-36. PubMed ID: 8947285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat.
    Mobini S; Chiang TJ; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Sep; 152(1):47-54. PubMed ID: 11041315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.